Reschedule psilocybin from Schedule 1 to 2 to allow for use in medical research

Summary

We ask the UK Government to reschedule psilocybin, moving it from Schedule 1 to Schedule 2 of the Misuse of Drugs Regulations 2001, to allow it to be used in clinical trials. We ask the UK Government to reschedule psilocybin from Schedule 1 to Schedule 2 to allow medical research. Some studies show psilocybin can reduce depression, anxiety, and PTSD symptoms under clinical supervision. Rescheduling could enable safe, regulated research and potential therapeutic use.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.